Société Tunisienne des Maladies Respiratoires et d'Allergologie STMRA - Efficacy of Pemetrexed as Second-Line Therapy in Advanced NSCLC after Either Treatment-Free Interval or Maintenance Therapy with Gemcitabine or Erlotinib in IFCT-GFPC 05-02 Phase III Study.

Sté Tunisienne des Maladies Respiratoires et d'Allergologie

Cercle des Bureaux - Appartement B 5-3 . 1082 Centre urbain Nord Tunis

Blog With Right Sidebar

: Zouhair Souissi; Bibliographie; 19 avril 2013; 19 avril 2013; Rating:

( 0 Rating )

Efficacy of Pemetrexed as Second-Line Therapy in Advanced NSCLC after Either Treatment-Free Interval or Maintenance Therapy with Gemcitabine or Erlotinib in IFCT-GFPC 05-02 Phase III Study.

Etoiles inactives

Etoiles inactives

Etoiles inactives

Etoiles inactives

Etoiles inactives

Author:

Read Full Article

Search